Prezcobix and Hydrocephalus - a phase IV clinical study of FDA data

Summary:

Hydrocephalus is reported as a side effect among people who take Prezcobix (cobicistat; darunavir ethanolate), especially for people who are female, 0-1 old, also take Cobicistat, and have Hiv infection.

The phase IV clinical study analyzes which people have Hydrocephalus when taking Prezcobix. It is created by eHealthMe based on reports of 2,108 people who have side effects when taking Prezcobix from the FDA, and is updated regularly.

What is Prezcobix?

Prezcobix has active ingredients of cobicistat; darunavir ethanolate. eHealthMe is studying from 2,113 Prezcobix users. Check the latest studies of Prezcobix.

What is Hydrocephalus?

Hydrocephalus (water on the brain) is found to be associated with 753 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Hydrocephalus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

2,108 people reported to have side effects when taking Prezcobix.
Among them, 14 people (0.66%) have Hydrocephalus.

Among these 14 people:

What is the gender of people who have Hydrocephalus when taking Prezcobix? *

female: 100 %
male: 0.0 %

What is the age of people who have Hydrocephalus when taking Prezcobix? *

What are other drugs people take besides Prezcobix? *

Lamivudine: 14 people, 100.00%
Darunavir: 14 people, 100.00%
Cobicistat: 14 people, 100.00%
Abacavir: 10 people, 71.43%
Abacavir Sulfate: 4 people, 28.57%
Raltegravir: 2 people, 14.29%
Darunavir Ethanolate: 2 people, 14.29%
Abacavir And Lamivudine: 1 person, 7.14%

What are other side effects people have besides Hydrocephalus? *

Head Injury: 14 people, 100.00%
Gastroschisis (a hole in the abdominal wall): 14 people, 100.00%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 14 people, 100.00%
Foetal Growth Restriction (poor growth of a baby while in the mother's womb during pregnancy): 12 people, 85.71%
Foetal Death (death of foetus): 12 people, 85.71%

What are the existing conditions these people have? *

Hiv Infection: 13 people, 92.86%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Prezcobix and have Hydrocephalus?

- Check whether Hydrocephalus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prezcobix:

Prezcobix (2,113 reports)

Hydrocephalus treatments and more:

Hydrocephalus (6,876 reports)

How severe was Hydrocephalus and when was it recovered:

Hydrocephalus in Prezcobix

Expand to all the drugs that have ingredients of cobicistat; darunavir ethanolate:

Hydrocephalus and drugs with ingredients of cobicistat; darunavir ethanolate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prezcobix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hydrocephalus:

Hydrocephalus (753 drugs)

Browse all the conditions that are associated with Hydrocephalus:

Hydrocephalus (1,370 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; darunavir ethanolate (the active ingredients of Prezcobix) and Prezcobix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.